Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review

References

• Parks R, Derks M, Bastiaannet E, Cheung K. Breast cancer epidemiology. In: Breast Cancer Management for Surgeons. Springer; 2018:19–29.
   Google Scholar
• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.21208
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31–42. doi:10.3322/caac.21320
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E86. doi:10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Robb GL, Hortobagyi GN. Advanced therapy of breast disease: PMPH-USA; 2004.
   Google Scholar
• Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132(4):620–6; discussion 6–7. doi:10.1067/msy.2002.127544
   Web of Science ®Google Scholar
• Ly BH, Nguyen NP, Vinh-Hung V, Rapiti E, Vlastos G. Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit? Breast Cancer Res Treat. 2010;119(3):537–545. doi:10.1007/s10549-009-0610-z
   PubMed Web of Science ®Google Scholar
• Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving? Cancer. 2004;100(1):44–52. doi:10.1002/cncr.11859
   PubMed Web of Science ®Google Scholar
• Thomas A, Khan SA, Chrischilles EA, Schroeder MC. Initial surgery and survival in stage IV breast cancer in the United States, 1988–2011. JAMA Surg. 2016;151(5):424–431. doi:10.1001/jamasurg.2015.4539
   PubMed Web of Science ®Google Scholar
• Sales C, Paiva L, Scandiuzzi D, Anjos AC. Quality of life of breast cancer survivors: social functioning. Rev Bras Cancerol. 2011;47(3):263–272. doi:10.32635/2176-9745.RBC.2001v47n3.2304
   Google Scholar
• Wang R, Zhu Y, Liu X, Liao X, He J, Niu L. The clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. BMC Cancer. 2019;19(1):1091. doi:10.1186/s12885-019-6311-z
   PubMed Web of Science ®Google Scholar
• Ruiterkamp J, Ernst MFJ. The role of surgery in metastatic breast cancer. Eur J Cancer. 2011;47:S6–S22. doi:10.1016/S0959-8049(11)70142-3
   PubMed Web of Science ®Google Scholar
• Poscia A, Collamati A, Milovanovic S, et al. Methodological issues in the observational studies conducted in older population: a narrative review. Epidemiol Biostat Public Health. 2017;14(2):e12627–e.
   Google Scholar
• Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006;13(6):776–782. doi:10.1245/ASO.2006.03.033
   PubMed Web of Science ®Google Scholar
• Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol. 2006;24(18):2743–2749. doi:10.1200/JCO.2005.04.2226
   PubMed Web of Science ®Google Scholar
• Fields RC, Jeffe DB, Trinkaus K, et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol. 2007;14(12):3345–3351. doi:10.1245/s10434-007-9527-0
   PubMed Web of Science ®Google Scholar
• Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988–2003 SEER data. Ann Surg Oncol. 2007;14(8):2187–2194. doi:10.1245/s10434-007-9438-0
   PubMed Web of Science ®Google Scholar
• Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg. 2008;247(5):732–738. doi:10.1097/SLA.0b013e3181656d32
   PubMed Web of Science ®Google Scholar
• Neuman HB, Morrogh M, Gonen M, Van ZKJ, Morrow M, King TA. Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer. 2010;116(5):1226–1233. doi:10.1002/cncr.24873
   PubMed Web of Science ®Google Scholar
• Ruiterkamp J, Ernst M, Van de Poll-Franse L, Bosscha K, Tjan-Heijnen V, Voogd A. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol. 2009;35(11):1146–1151. doi:10.1016/j.ejso.2009.03.012
   PubMed Web of Science ®Google Scholar
• Cady B, Nathan N, Michaelson J, Golshan M, Smith B. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Ann Surg Oncol. 2008;15(12):3384–3395. doi:10.1245/s10434-008-0085-x
   PubMed Web of Science ®Google Scholar
• Leung AM, Vu HN, Nguyen K-A, Thacker LR, Bear HD. Effects of surgical excision on survival of patients with stage IV breast cancer. J Surg Res. 2010;161(1):83–88. doi:10.1016/j.jss.2008.12.030
   PubMed Web of Science ®Google Scholar
• Soran A, Ozmen V, Ozbas S, et al. A randomized controlled trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer: Turkish Study (protocol MF07-01). Am J Clin Oncol. 2016;34:1005. doi:10.1200/JCO.2016.34.15_suppl.1005
   Google Scholar
• Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. 2015;16(13):1380–1388. doi:10.1016/s1470-2045(15)00135-7
   PubMed Web of Science ®Google Scholar
• Bjelic-Radisic V, Fitzal F, Knauer M, et al. Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 positive trial. BMC Cancer. 2020;20(1):392. doi:10.1186/s12885-020-06894-2
   PubMed Web of Science ®Google Scholar
• Khan SA, Zhao F, Solin LJ, et al. A randomized Phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: a trial of the ECOG-ACRIN research group (E2108). Am J Clin Oncol. 2020;38:LBA2–LBA2. doi:10.1200/JCO.2020.38.18_suppl.LBA2
   Web of Science ®Google Scholar
• Loeffler JS, Wen P. Epidemiology, Clinical Manifestations, and Diagnosis of Brain Metastases. Waltham, MA: Google Scholar; 2018.
   Google Scholar
• Loeffler JS, Wen P. Overview of the Treatment of Brain Metastases. Waltham, MA: Wolters Kluwer; 2020.
   Google Scholar
• Wiegel T, Kreusel KM, Bornfeld N, et al. Frequency of asymptomatic choroidal metastasis in patients with disseminated breast cancer: results of a prospective screening programme. Br J Ophthalmol. 1998;82(10):1159–1161. doi:10.1136/bjo.82.10.1159
   PubMed Web of Science ®Google Scholar
• Mewis L, Young SE. Breast carcinoma metastatic to the choroid. Analysis of 67 patients. Ophthalmology. 1982;89(2):147–151. doi:10.1016/s0161-6420(82)34838-1
   PubMed Web of Science ®Google Scholar
• Georgalas I, Paraskevopoulos T, Koutsandrea C, et al. Ophthalmic metastasis of breast cancer and ocular side effects from breast cancer treatment and management: mini review. Biomed Res Int. 2015;2015:574086. doi:10.1155/2015/574086
   PubMed Web of Science ®Google Scholar
• Wiegel T, Bottke D, Kreusel KM, et al. External beam radiotherapy of choroidal metastases--final results of a prospective study of the German Cancer Society (ARO 95-08). Radiother Oncol. 2002;64(1):13–18. doi:10.1016/s0167-8140(02)00134-2
   PubMed Web of Science ®Google Scholar
• Mathis T, Jardel P, Loria O, et al. New concepts in the diagnosis and management of choroidal metastases. Prog Retin Eye Res. 2019;68:144–176. doi:10.1016/j.preteyeres.2018.09.003
   PubMed Web of Science ®Google Scholar
• Lutz S, Balboni T, Jones J, et al. Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017;7(1):4–12. doi:10.1016/j.prro.2016.08.001
   PubMed Web of Science ®Google Scholar
• Chow R, Hoskin P, Schild SE, et al. Single vs multiple fraction palliative radiation therapy for bone metastases: cumulative meta-analysis. Radiother Oncol. 2019;141:56–61. doi:10.1016/j.radonc.2019.06.037
   PubMed Web of Science ®Google Scholar
• Staren ED, Salerno C, Rongione A, Witt TR, Faber LP. Pulmonary resection for metastatic breast cancer. Arch Surg. 1992;127(11):1282–1284. doi:10.1001/archsurg.1992.01420110024006
   PubMedGoogle Scholar
• Cahan WG, Castro EB. Significance of a solitary lung shadow in patients with breast cancer. Ann Surg. 1975;181(2):137–143. doi:10.1097/00000658-197502000-00002
   PubMed Web of Science ®Google Scholar
• Casey JJ, Stempel BG, Scanlon EF, Fry WA. The solitary pulmonary nodule in the patient with breast cancer. Surgery. 1984;96(4):801–805.
   PubMed Web of Science ®Google Scholar
• Friedel G, Pastorino U, Ginsberg RJ, et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the international registry of lung metastases. Eur J Cardiothorac Surg. 2002;22(3):335–344. doi:10.1016/s1010-7940(02)00331-7
   PubMed Web of Science ®Google Scholar
• Planchard D, Soria JC, Michiels S, et al. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Cancer. 2004;100(1):28–35. doi:10.1002/cncr.11881
   PubMed Web of Science ®Google Scholar
• Yoshimoto M, Tada K, Nishimura S, et al. Favourable long-term results after surgical removal of lung metastases of breast cancer. Breast Cancer Res Treat. 2008;110(3):485–491. doi:10.1007/s10549-007-9747-9
   PubMed Web of Science ®Google Scholar
• Meimarakis G, Rüttinger D, Stemmler J, et al. Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer. Ann Thorac Surg. 2013;95(4):1170–1180. doi:10.1016/j.athoracsur.2012.11.043
   PubMed Web of Science ®Google Scholar
• Fan J, Chen D, Du H, Shen C, Che G. Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis. J Thorac Dis. 2015;7(8):1441–1451. doi:10.3978/j.issn.2072-1439.2015.08.10
   PubMed Web of Science ®Google Scholar
• Hoe AL, Royle GT, Taylor I. Breast liver metastases--incidence, diagnosis and outcome. J R Soc Med. 1991;84(12):714–716. doi:10.1177/014107689108401207
   PubMed Web of Science ®Google Scholar
• Atalay G, Biganzoli L, Renard F, et al. Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. Eur J Cancer. 2003;39(17):2439–2449. doi:10.1016/s0959-8049(03)00601-4
   PubMed Web of Science ®Google Scholar
• Veltri A, Gazzera C, Barrera M, et al. Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease. Radiol Med. 2014;119(5):327–333. doi:10.1007/s11547-013-0354-z
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003;10(9):1059–1069. doi:10.1245/aso.2003.03.026
   PubMed Web of Science ®Google Scholar
• Livraghi T, Goldberg SN, Solbiati L, Meloni F, Ierace T, Gazelle GS. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology. 2001;220(1):145–149. doi:10.1148/radiology.220.1.r01jl01145
   PubMed Web of Science ®Google Scholar
• Chua TC, Saxena A, Liauw W, Chu F, Morris DL. Hepatic resection for metastatic breast cancer: a systematic review. Eur J Cancer. 2011;47(15):2282–2290. doi:10.1016/j.ejca.2011.06.024
   PubMed Web of Science ®Google Scholar
• Sadot E, Lee SY, Sofocleous CT, et al. Hepatic resection or ablation for isolated breast cancer liver metastasis: a case-control study with comparison to medically treated patients. Ann Surg. 2016;264(1):147–154. doi:10.1097/sla.0000000000001371
   PubMed Web of Science ®Google Scholar
• Washington K, McDonagh D. Secondary tumors of the gastrointestinal tract: surgical pathologic findings and comparison with autopsy survey. Mod Pathol. 1995;8(4):427–433.
   PubMed Web of Science ®Google Scholar
• Quan ML, Fey J, Eitan R, et al. Role of laparoscopy in the evaluation of the adnexa in patients with stage IV breast cancer. Gynecol Oncol. 2004;92(1):327–330. doi:10.1016/j.ygyno.2003.10.026
   PubMed Web of Science ®Google Scholar
• Li W, Wang H, Wang J, L VF, Zhu X, Wang Z. Ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients. BMC Cancer. 2012;12:278. doi:10.1186/1471-2407-12-278
   PubMed Web of Science ®Google Scholar
• Bland KI, Copeland EM, Klimberg VS, Gradishar WJ. The Breast E-Book: Comprehensive Management of Benign and Malignant Diseases. Elsevier Health Sciences; 2017.
   Google Scholar
• Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449(7162):557–563. doi:10.1038/nature06188
   PubMed Web of Science ®Google Scholar
• Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res. 2004;64(6):2205–2211. doi:10.1158/0008-5472.can-03-2646
   PubMed Web of Science ®Google Scholar
• Caswell-Jin JL, Plevritis SK, Tian L, et al. Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review. JNCI Cancer Spectr. 2018;2(4):pky062. doi:10.1093/jncics/pky062
   PubMed Web of Science ®Google Scholar
• Gennari A, André F, Barrios CH, et al. ESMO clinical practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. Ann Oncol. 2021;32(12):1475–1495. doi:10.1016/j.annonc.2021.09.019
   PubMed Web of Science ®Google Scholar
• Cardoso F, Paluch-Shimon S, Senkus E, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol. 2020;31(12):1623–1649. doi:10.1016/j.annonc.2020.09.010
   PubMed Web of Science ®Google Scholar